HU173783B - Sposob poluchenija monopeptidaminov - Google Patents

Sposob poluchenija monopeptidaminov

Info

Publication number
HU173783B
HU173783B HU74TA323A HUTA001323A HU173783B HU 173783 B HU173783 B HU 173783B HU 74TA323 A HU74TA323 A HU 74TA323A HU TA001323 A HUTA001323 A HU TA001323A HU 173783 B HU173783 B HU 173783B
Authority
HU
Hungary
Prior art keywords
nonapeptide
amides
preparing
preparing nonapeptide
Prior art date
Application number
HU74TA323A
Other languages
English (en)
Inventor
Masahiko Fujino
Tsunehiko Fukuda
Susumu Shinagawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26365357&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU173783(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP10995173A external-priority patent/JPS5314072B2/ja
Priority claimed from JP2744274A external-priority patent/JPS5726506B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HU173783B publication Critical patent/HU173783B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU74TA323A 1973-09-29 1974-09-27 Sposob poluchenija monopeptidaminov HU173783B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10995173A JPS5314072B2 (hu) 1973-09-29 1973-09-29
JP2744274A JPS5726506B2 (hu) 1974-03-08 1974-03-08

Publications (1)

Publication Number Publication Date
HU173783B true HU173783B (hu) 1979-08-28

Family

ID=26365357

Family Applications (1)

Application Number Title Priority Date Filing Date
HU74TA323A HU173783B (hu) 1973-09-29 1974-09-27 Sposob poluchenija monopeptidaminov

Country Status (17)

Country Link
US (1) US4008209A (hu)
AT (1) AT347054B (hu)
BE (1) BE820451A (hu)
CA (1) CA1027114A (hu)
CH (1) CH603559A5 (hu)
CS (1) CS180644B2 (hu)
DE (1) DE2446005C2 (hu)
DK (1) DK148305C (hu)
ES (1) ES430495A1 (hu)
FI (1) FI61028C (hu)
FR (1) FR2245375B1 (hu)
GB (1) GB1434694A (hu)
HK (1) HK15579A (hu)
HU (1) HU173783B (hu)
NL (3) NL179289C (hu)
NO (2) NO143218C (hu)
SE (1) SE420717B (hu)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
US4215038A (en) * 1978-10-16 1980-07-29 The Salk Institute For Biological Studies Peptides which inhibit gonadal function
US4359312A (en) * 1978-08-15 1982-11-16 Zumtobel Kg Reciprocating pump for the pulsation-free delivery of a liquid
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
ZA815447B (en) * 1980-08-29 1982-08-25 Salk Inst For Biological Studi Peptides affecting gonadal function
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
CS230614B1 (en) * 1982-08-06 1984-08-13 Martin Cs Flegel Analogues of realising factor for luteining and folliculstimulated hormon
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
DE3411224A1 (de) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
HU193093B (en) * 1985-04-16 1987-08-28 Innofinance Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
DE69429603T2 (de) 1993-09-22 2002-08-14 Hisamitsu Pharmaceutical Co Iontophoresematrix
CA2143044C (en) * 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
IL115099A (en) 1994-10-14 1999-04-11 Upjohn Co Lyophilizate of phospholipid complex of water insoluble camptothecins
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20050042679A1 (en) * 1999-04-15 2005-02-24 Monash University Diagnostic indicator of thymic function
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
EP1207167B1 (en) * 1999-06-30 2006-10-04 Takeda Pharmaceutical Company Limited Process for the preparation of lh-rh derivatives
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
ATE413164T1 (de) * 2000-11-09 2008-11-15 Neopharm Inc Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
CA2540838C (en) 2003-10-03 2014-12-16 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
JP2008534628A (ja) 2005-05-03 2008-08-28 ノベタイド，リミティド ペプチド誘導体の製造のための方法
EP1790656A1 (en) 2005-11-25 2007-05-30 Nanokem S.A. Solution-phase synthesis of leuprolide
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
BRPI1014362A2 (pt) 2009-04-23 2016-04-05 Pennatek Llc método e composição para sincronizar o tempo de inseminação
EP2762133A1 (en) 2010-04-01 2014-08-06 CHIESI FARMACEUTICI S.p.A. Process for preparing carrier particles for dry powders for inhalation
EP2566883A1 (en) 2010-05-07 2013-03-13 Mylan Laboratories, Limited Novel process for the preparation of leuprolide and its pharmaceutically acceptable salts thereof
EP2611416B1 (en) 2010-09-03 2015-08-19 Pharmaterials Ltd. Pharmaceutical composition suitable for use in a dry powder inhaler
JP2016508030A (ja) 2012-11-28 2016-03-17 ジェイビーエス ユナイテッド アニマル ヘルス セカンド エルエルシー 未経産ブタにおける授精の時期を同期化するための方法および組成物
CN103012564B (zh) * 2013-01-15 2013-11-13 成都天台山制药有限公司 高纯度的曲普瑞林及其纯化方法
CN103012565B (zh) * 2013-01-15 2014-07-16 成都天台山制药有限公司 一种曲普瑞林及其固相合成制备方法
CN104402977B (zh) * 2014-12-08 2017-11-14 泰州启瑞医药科技有限公司 一种布舍瑞林的固液合成方法
WO2018085495A2 (en) 2016-11-02 2018-05-11 Board Of Regents, The University Of Texas System Dissolvable films and methods of their use
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity

Also Published As

Publication number Publication date
FI61028B (fi) 1982-01-29
FI61028C (fi) 1982-05-10
CA1027114A (en) 1978-02-28
CH603559A5 (hu) 1978-08-31
BE820451A (fr) 1975-03-27
NL930121I1 (nl) 1993-11-01
FR2245375A1 (hu) 1975-04-25
FR2245375B1 (hu) 1978-07-21
SE420717B (sv) 1981-10-26
NL930015I1 (nl) 1993-05-03
NO143218B (no) 1980-09-22
DK510374A (hu) 1975-05-26
AT347054B (de) 1978-12-11
DK148305B (da) 1985-06-03
HK15579A (en) 1979-03-30
GB1434694A (en) 1976-05-05
SE7412140L (hu) 1975-04-01
CS180644B2 (en) 1978-01-31
FI284774A (hu) 1975-03-30
DE2446005A1 (de) 1975-04-03
ATA772674A (de) 1978-04-15
ES430495A1 (es) 1977-01-16
NO1994010I1 (no) 1994-08-18
NL930015I2 (nl) 1993-11-01
DE2446005C2 (de) 1982-03-18
DK148305C (da) 1985-12-02
NL7412837A (nl) 1975-04-02
NO143218C (no) 1981-01-02
US4008209A (en) 1977-02-15
NL179289B (nl) 1986-03-17
NO743538L (hu) 1975-04-28
NL179289C (nl) 1986-08-18

Similar Documents

Publication Publication Date Title
HU173783B (hu) Sposob poluchenija monopeptidaminov
YU127874A (en) Process for obtaining compolyamides
HU174374B (hu) Sposob poluchenija 7-trans-9-cis-dodekadien-1-il-acetata
CS187409B2 (en) Process for preparing alpha-aminoacyl-halogen-cephalosporine compounds
CS183763B2 (en) Process for preparing d-homosteroides
CS189623B2 (en) Process for preparing 4-imidothiazetidin-2-one
YU25374A (en) Process for obtaining 6delta-deoxytetracyline
JPS5373556A (en) Process for preparing 22aromatical ketoneoxim
JPS5384958A (en) Process for preparing 222dehydroohomocholene
CS189676B2 (en) Process for preparing poly-n-alkyliminoalanes
CS187441B2 (en) Process for preparing 7-acylamido-7-methoxy-cephalosporine compounds
YU156674A (en) Process for preparing n-arylsulfonyl-n-(aza-3-bicycloalkyl)-carbamides
HU172656B (hu) Sposob poluchenija novykh d-homo-steroidov
IL45804A0 (en) Process for preparing n-trimetylsilylacetamide
JPS5390288A (en) Process for preparing 77trichloroacetamidee33desacetoxyy cephalosporane
GB1404442A (en) Process for preparing 3-anilino-pyrazolones-5
HU172196B (hu) Sposob poluchenija novykh zamehhjonnykh ciklogeksantetrolov
ZA743473B (en) Process for preparing 5-oxohexanenitrile
IL45977A0 (en) Process for preparing cis-olefins
YU279774A (en) Process for obtaining 4-oxo-2-imidazolidinylidene-urea
CS183759B2 (en) Process for preparing acylaminophenylacetamidines
CS189663B2 (en) Process for preparing alpha-ethinylbenzhydroles
CS182269B2 (en) Process for preparing alkylnaphtalenes
YU13274A (en) Process for preparing 4-acetamidophenyl-2-acetoxybenzoate
IL44210A0 (en) Process for preparing 4-hydroxythiochromans